Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 20 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

10%

1 of 10 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

9Total
Not Applicable (9)

Trial Status

Completed10
Unknown6
Active Not Recruiting2
Enrolling By Invitation1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT07400835Enrolling By InvitationPrimary

Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding

NCT07366814Not ApplicableCompleted

Pipelle Versus Karman Endometrial Biopsy Under Standardized Paracervical Block

NCT03382145CompletedPrimary

A Review on the Outcome of Patient Managed in Postmenopausal Bleeding Clinic

NCT07074795Not ApplicableActive Not Recruiting

Use of Nitrous Oxide During Office Hysteroscopy

NCT06501846Not ApplicableRecruiting

Pipelle® Under Ultrasound Guidance (PUG) to Investigate Post-menopausal Bleeding.

NCT06293066Active Not RecruitingPrimary

Performance of Ultrasound in Women With Postmenopausal or Abnormal Uterine Bleeding Between White and Black Ethnic Groups- a Retrospective Cohort Study.

NCT05378152Not ApplicableCompletedPrimary

Assessing the Benefit of Pipelle Biopsy in Patients With Postmenopausal Bleeding and an Atrophic-appearing Cavity

NCT06004908UnknownPrimary

Role of MRI in Diagnosis of Postmenopausal Bleeding Causes

NCT04500496Not ApplicableUnknownPrimary

Vaginal Dinoprostone Versus Isonicotinic Acid Hydrazide Prior to Diagnostic Office Hysteroscopy

NCT00339651Completed

Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer

NCT03543592Not ApplicableUnknownPrimary

Three-dimensional Power Doppler in the Diagnosis of Endometrial Lesions in Patients With Postmenopausal Bleeding

NCT03427957Not ApplicableCompletedPrimary

Evaluation of a New Hysteroscopic Grasper for Endometrial Biopsy in Post-menopausal Patients

NCT03841916UnknownPrimary

Relation Between Body Mass Index and Endometrial Thickness

NCT03847415UnknownPrimary

Endometrial Evaluation in Cases of Postmenopausal Bleeding

NCT03404154CompletedPrimary

Vocal in Assessment of Endometrium in Postmenopause

NCT03558321Not ApplicableCompletedPrimary

Relation Between Human Epididymis Protein 4 (HE4) and Endometrial Pathology in Patients With Postmenopausal Bleeding

NCT03330015Completed

Patient's Experience and Choice Between Investigations for Endometrial Cancer in Postmenopausal Bleeding

NCT02822885Not ApplicableUnknownPrimary

Uterine Artery and Spiral Artery Doppler Parameters in Patients With Postmenopausal Bleeding

NCT02488798CompletedPrimary

Office Hysteroscopy and 3D Power Doppler Vaginal Ultrasound in Assessment of Postmenopausal Bleeding

NCT01076621Completed

Observational Study to Investigate the Occurrence of Bleeding in Postmenopausal Women Treated With Estradiol/NETA for 12 Months

Showing all 20 trials

Research Network

Activity Timeline